Select Page

Early Career Researchers > Subcommittee

The inaugural IUPHAR Early Career (EC) Researchers Subcommittee was selected by the IUPHAR Executive Committee from nominations received from IUPHAR member societies. They will serve a 4 year term from 2018-2022.

Current Members of EC Researchers Subcommittee

Dr. Aisah Aubdool

– Chair –

(British Pharmacological Society)

Aisah Aubdool is a postdoctoral research fellow at the William Harvey Research Institute, where she studies the role of C-type natriuretic peptide in angiogenesis and vascular remodelling in the lab of Prof. Adrian Hobbs. Prior to this, she graduated with a BSc (Hons) in Pharmacology and completed her PhD in Cardiovascular Medical Research under the mentorship of Prof. Susan Brain at King’s College London. Aisah is currently the  Chair of the IUPHAR EC Researchers Committee, BPS’ Public Engagement & Policy Committee member, Pharmacology Matters Editor and the BPS Ambassador Coordinator.

Dr. Raffaele Coppini

Committee Member –

(Italian Pharmacological Society)

Raffaele Coppini received his medical degree in 2007 and his PhD in Pharmacology and Toxicology in 2011 at the University of Florence, Italy. He received medical specialty degree in Clinical Pharmacology in 2016. He is currently a staff scientist in the Department NeuroFarBa of the University of Florence and runs a laboratory of cardiac cell electrophysiology. He has authored over 40 papers in peer-reviewed international journals. He is a long-term member of the European Society of Cardiology, the Italian Cardiology Society and the Italian Pharmacological Society.

Dr. Sanseray da Silveira Cruz-Machado

Committee Member –

(Brazilian Society of Pharmacology and Experimental Therapeutics)

Sanseray da Silveira Cruz-Machado received his bachelor´s degree in Physical Therapy from the Centro Universitário de Itajubá (Brazil) and earned his Ph.D in Physiology at the University of Sao Paulo (Brazil). He serves on the Board of the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFTE) (2016-2021). His research was pioneer to disclose how inflammatory molecules switches the sources of melatonin production during the activation of the Immune-Pineal Axis. His research now focusses in chronopharmacological approaches for modulating energy metabolism and the role of melatonin receptors in the regulation of immunometabolic responses along with the gain of body weight in both rodent and human models

Dr ‘Makhotso Lekhooa

Committee Member –

Subcommittee engagement officer (South African Society of Basic and Clinical Pharmacology)

Dr Lekhooa is a senior lecturer in pharmacology at the North West University, Potchefstroom campus. She is involved in teaching and research Ethnopharmacology and neuropsychiatric.  She serves as a reviewer on the complementary medicines sub-committee of South African Health products regulatory agency of the National departmental of health.  Dr Lekhooa is also active on pharmacological forums at national (Secretary General of South African society of basic and clinical pharmacology), continental (Liaison of Pharmacology for Africa initiative).

Assoc. Prof. Volker Lauschke

– Committee Member –

(Swedish Society for Pharmacology, Clinical Pharmacology and Therapeutics)

Obtained his Ph.D. from the EMBL and the Combined Faculty of Natural Sciences and Mathematics of the University of Heidelberg for work on tissue patterning based on phase gradient-encoding using molecular oscillators. In 2014, he moved to Karolinska Institutet (KI) as a MarieCurie fellow and became Associate Professor of Personalized Medicine and Drug Development in 2018. His research group uses 3D cell culture systems of primary human cells, microfluidics and integrative bioinformatics approaches to develop better model systems for prediction of drug toxicity and to identify novel therapeutic strategies for complex metabolic diseases, such as type 2 diabetes. In addition, his lab develops pharmacogenomic algorithms to improve personalized pharmacological therapy.

Dr Udeme Owunari Georgewill MBBCh, Ph.D. Pharmacology

Committee Member –

(West African Society for Pharmacology)

Is a medical doctor, Senior Lecturer and acting Head of the Department of Pharmacology at the University of Port Harcourt, Nigeria. She has special interest in drug repurposing and its toxicological implications. She was nominated to the committee on the platform of the West African Society of Pharmacology. She is married with children.

Dr Ye Htut Linn

– Committee Member –

(Myanmar Pharmacology Society)

Is an Assistant Lecturer at the Department of Pharmacology, University of Medicine 1, Yangon, Myanmar. He was trained as a medical doctor (2012) and received his Masters degree in 2017. His areas of interest are probiotics, bioequivalence, therapeutic drug monitoring and drug utilization.

Dr. Vanessa Minervini

Committee Member

(American Society for Pharmacology and Experimental Therapeutics)

Dr. Minervini earned her masters and PhD in psychology at the University of Florida in Gainesville, FL. She then completed a postdoctoral fellowship in pharmacology at the University of Texas Health Science Center in San Antonio, TX. As a postdoctoral fellow she received NIH funding to evaluate therapeutic (analgesic) and adverse effects of opioid drugs alone and in mixtures and found that opioid mixtures could effectively treat pain in the absence of adverse effects. Dr. Minervini currently is an Assistant Professor in the department of Psychological Science at Creighton University in Omaha, NE.

Dr. Seunghoon Han

Committee Member –

(Korean Society of Pharmacology)

Seunghoon Han is an Assistant Professor at the Catholic University of Korea. The main area of research is drug development and pharmacotherapy optimization and is participating in the first and the only pharmacometrics institute in Korea as a faculty member. Prior to this, he completed PhD in Clinical Pharmacology under the supervision of Prof. Dong-Seok Yim at the Catholic University of Korea. Seunghoon is currently a member of the Korean Society of Pharmacology, the Korean Society of Clinical Pharmacology and Therapeutics.

Dr. Gabriel Chin Kok-Yong

Committee Member –

(Malaysian Society of Pharmacology and Physiology)

Dr Kok-Yong Chin obtained his Biomedical Science degree in 2006 and PhD (Pharmacology) in 2015 from University Kebangsaan Malaysia. He currently serves as a senior lecturer in the Department of Pharmacology, Faculty of Medicine, University Kebangsaan Malaysia. He has a research interest in the actions of vitamin E on the musculoskeletal system and the epidemiology of bone health among the Malaysian population. He was awarded the Young Scientist Award by Malaysian Society of Pharmacology and Physiology in 2018.

Dr. Hong Yong Peh

Committee Member –

(Pharmacology Society of Singapore)

Hong Yong received his PhD in Medicine (immuno-pharmacology) from National University of Singapore in 2017. He is currently co-appointed as a Postdoctoral Research Fellow at Harvard Medical School and Brigham and Women’s Hospital (USA), and a Senior Tutor in the Department of Pharmacology at Yong Loo Lin School of Medicine (Singapore). His research interests are developing pre-clinical animal models, and the use of vitamin E tocotrienols and specialized pro-resolving mediators as potential therapies in asthma, COPD, lung injury and wound healing on the skin. Pharmacology is a critical field required in tackling current medical needs, and he wishes to inspire young pharmacologists, as well as promoting the field of pharmacology.

Dr. Christina Perez-Tornero

Committee Member –

(Spanish Society of Pharmacology)

Christina completed undergraduate studies on Pharmacy at the University of Seville (Spain) in 2011 and completed a PhD on the protective effects of rice bran diet supplementation on atherosclerosis development. Christina is now undertaking post-doctoral studies with Professor Adrian Hobbs’ investigating the role of CNP in cardiovascular related diseases.
Simon Foster

Dr. Simon Foster

Committee Member –

(Australiasian Society of Clinical and Experimental Pharmacologists and Toxicologists)

Dr. Simon Foster is a Senior Research Officer at QIMR Berghofer Medical Research Institute and is an Adjunct Research Fellow at Monash University and an Honorary Fellow at the University of Queensland. After receiving his PhD (University of Queensland) in 2014, Simon led a large project on orphan GPCRs at University of Copenhagen, where he was supported by consecutive Postdoctoral fellowships from the Lundbeck Foundation and the Danish Council for Independent Research. He returned to Australia in 2018 to Monash University, and then joined the Cardiac Bioengineering (Hudson) Group at QIMR Berghofer in late 2020. Simon is now combining his research interests in cardiovascular pharmacology, cell signalling and drug discovery with the powerful cardiac organoid platform pioneered in the Hudson lab. Simon has been an active member of ASCEPT since 2005 and currently serves on the board of ASCEPT as the IUPHAR EC Researchers Committee representative.
Previous Members of EC Researchers Subcommittee

Dr. Maha Abdollah

Ex Committee Member –

(Egyptian Society of Pharmacology and Experimental Therapeutics)

Dr Maha R.A. Abdollah graduated from the Faculty of Pharmacy, Ain Shams University in Cairo, Egypt in 2006. She received her Masters degree in Cancer (MSc Cancer) from University College London (UCL) in London, UK in 2011. She completed PhD in 2016, and is now a lecturer of pharmacology at the British University in Egypt (BUE) where she is also currently doing research involving hepatocellular carcinoma (HCC) and drug repositioning.

Dr. Carl White

– Ex Chair (2018-2020) –

(Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists)


Dr. Carl White was awarded is PhD in Pharmacology from Monash University in 2013. He is currently an NHMRC CJ Martin early career research fellow based at the Harry Perkins Institute of Medical Research, University of Western Australia and University of Nottingham. He is a molecular pharmacologist investigating the effect of GPCR dimerization using genome-editing and BRET based biophysical techniques. Carl has been an active member of ASCEPT since 2008 and currently serves on the executive boards of IUPHAR and ASCEPT as the young investigator member.